Compare Solaredge Technologies Inc (SEDG) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Solaredge Technologies Inc vs TransMedics Group Inc — how do they compare? Solaredge Technologies Inc trades at $34.89 (market cap $2.17B), while TransMedics Group Inc trades at $86.5 (market cap $3.00B). The key difference: TransMedics Group Inc is the larger of the two by market cap, and TransMedics Group Inc is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals.
| SEDG | TMDX | |
|---|---|---|
Market Cap | $2.17B | $3.00B |
Sector | Technology | Technology |
52-Week High | $78.51 | $150.42 |
52-Week Low | $28.47 | $61.99 |
Enterprise Value | $2.03B | $3.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SolarEdge (SEDG) trades at $36.43, up 6.52% today, with a bullish technical signal despite negative profitability. Revenue declined to $1.18B in 2025, with a net loss of $405M, though recent quarterly EPS beat expectations. The stock shows improved cash flow from operations at $104M in 2025, and news highlights collaboration with Infineon for AI data center technology, driving positive sentiment.
Outlook remains cautious due to persistent losses and high debt, but analyst consensus price target of $41 offers 12.5% upside. Key risks include reliance on policy incentives and competitive pressures. Institutional sentiment is mixed with 23% buy ratings, suggesting patience for margin recovery and AI-related growth catalysts.
TransMedics Group (TMDX) trades at $88.27, down 1.9% on the day, with a bullish technical signal from moving averages but mixed earnings performance. The company reported strong 2025 results with $605M revenue and 31.4% net margin, though 2026 projections show margin compression. Recent news highlights growth initiatives in kidney transplantation and European markets, alongside ongoing legal investigations into fiduciary duties.
The stock offers upside to the $99.57 consensus price target, supported by analyst bullishness (69% buy ratings), but faces risks from margin pressure, legal scrutiny, and earnings misses. Revenue growth remains a key catalyst, though execution risks and investor sentiment headwinds warrant caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
